TY - JOUR
T1 - Patterns of care in hilar node-positive (N1) non-small cell lung cancer
T2 - A missed treatment opportunity? Read at the 41st Annual Meeting of the Western Thoracic Surgical Association, Whistler, British Columbia, Canada, June 25, 2015.
AU - Bott, Matthew J.
AU - Patel, Aalok P.
AU - Verma, Vivek
AU - Crabtree, Traves D.
AU - Morgensztern, Daniel
AU - Robinson, Clifford G.
AU - Colditz, Graham A.
AU - Waqar, Saiama
AU - Kreisel, Daniel
AU - Krupnick, A. Sasha
AU - Patterson, G. Alexander
AU - Broderick, Stephen
AU - Meyers, Bryan F.
AU - Puri, Varun
N1 - Publisher Copyright:
Copyright © 2016 by The American Association for Thoracic Surgery.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Background For patients with non-small cell lung cancer (NSCLC) metastatic to hilar lymph nodes (N1), guidelines recommend surgery and adjuvant chemotherapy in operable patients and chemoradiation (CRT) for those deemed inoperable. It is unclear how these recommendations are applied nationally, however. Methods The National Cancer Database was queried to identify patients with a tumor <7 cm (T1/T2) with clinically positive N1 nodes. Patients undergoing CRT (comprising chemotherapy and radiation >45 Gy) or surgical resection were considered adequately treated. Remaining patients were classified as receiving inadequate or no treatment. Results Of the 20,366 patients who met the study criteria, 63% underwent adequate treatment (48% surgical resection, 15% CRT). The remainder received inadequate treatment (23%) or no treatment (14%). In univariate analysis, the patients receiving inadequate or no treatment were older, tended to be non-Caucasian, had a lower income, and had a higher comorbidity score. Patients undergoing adequate treatment had improved overall survival (OS) compared with those receiving inadequate or no treatment (median OS, 34.0 months vs 11.7 months; P <.001). Of those receiving adequate treatment, logistic regression identified several variables associated with surgical resection, including treatment at an academic facility, Caucasian race, and annual income >$35,000. Increasing age and T2 stage were associated with nonoperative management. Following propensity score matching of 2308 patient pairs undergoing surgery or CRT, resection was associated with longer median OS (34.1 months vs 22.0 months; P <.001). Conclusions Despite the established guidelines, many patients with T1-2N1 NSCLC do not receive adequate treatment. Surgery is associated with prolonged survival in selected patients. Surgical input in the multidisciplinary evaluation of these patients should be mandatory.
AB - Background For patients with non-small cell lung cancer (NSCLC) metastatic to hilar lymph nodes (N1), guidelines recommend surgery and adjuvant chemotherapy in operable patients and chemoradiation (CRT) for those deemed inoperable. It is unclear how these recommendations are applied nationally, however. Methods The National Cancer Database was queried to identify patients with a tumor <7 cm (T1/T2) with clinically positive N1 nodes. Patients undergoing CRT (comprising chemotherapy and radiation >45 Gy) or surgical resection were considered adequately treated. Remaining patients were classified as receiving inadequate or no treatment. Results Of the 20,366 patients who met the study criteria, 63% underwent adequate treatment (48% surgical resection, 15% CRT). The remainder received inadequate treatment (23%) or no treatment (14%). In univariate analysis, the patients receiving inadequate or no treatment were older, tended to be non-Caucasian, had a lower income, and had a higher comorbidity score. Patients undergoing adequate treatment had improved overall survival (OS) compared with those receiving inadequate or no treatment (median OS, 34.0 months vs 11.7 months; P <.001). Of those receiving adequate treatment, logistic regression identified several variables associated with surgical resection, including treatment at an academic facility, Caucasian race, and annual income >$35,000. Increasing age and T2 stage were associated with nonoperative management. Following propensity score matching of 2308 patient pairs undergoing surgery or CRT, resection was associated with longer median OS (34.1 months vs 22.0 months; P <.001). Conclusions Despite the established guidelines, many patients with T1-2N1 NSCLC do not receive adequate treatment. Surgery is associated with prolonged survival in selected patients. Surgical input in the multidisciplinary evaluation of these patients should be mandatory.
KW - locally advanced
KW - lymph nodes
KW - multi-modality therapy
KW - non-small cell lung cancer
KW - practice patterns
KW - surgical resection
UR - http://www.scopus.com/inward/record.url?scp=84971668432&partnerID=8YFLogxK
U2 - 10.1016/j.jtcvs.2016.01.058
DO - 10.1016/j.jtcvs.2016.01.058
M3 - Article
C2 - 27207124
AN - SCOPUS:84971668432
SN - 0022-5223
VL - 151
SP - 1549-1558.e2
JO - Journal of Thoracic and Cardiovascular Surgery
JF - Journal of Thoracic and Cardiovascular Surgery
IS - 6
ER -